A functional variant in GREM1 confers risk for colorectal cancer by disrupting a hsa-miR-185-3p binding site.
Li J, Liu H, Zou L, Ke J, Zhang Y, Zhu Y, Yang Y, Gong Y, Tian J, Zou D, Peng X, Gong J, Zhong R, Huang K, Chang J, Miao X.
Li J, et al.
Oncotarget. 2017 May 23;8(37):61318-61326. doi: 10.18632/oncotarget.18095. eCollection 2017 Sep 22.
Oncotarget. 2017.
PMID: 28977865
Free PMC article.